573 related articles for article (PubMed ID: 30097388)
1. Comparison of clinical characteristics of bacteremia from Elizabethkingia meningoseptica and other carbapenem-resistant, non-fermenting Gram-negative bacilli at a tertiary medical center.
Huang YC; Wu PF; Lin YT; Wang FD
J Microbiol Immunol Infect; 2019 Apr; 52(2):304-311. PubMed ID: 30097388
[TBL] [Abstract][Full Text] [Related]
2. Emergence of Carbapenem Resistant Non-Fermenting Gram-Negative Bacilli Isolated in an ICU of a Tertiary Care Hospital.
Agarwal S; Kakati B; Khanduri S; Gupta S
J Clin Diagn Res; 2017 Jan; 11(1):DC04-DC07. PubMed ID: 28273965
[TBL] [Abstract][Full Text] [Related]
3. Comparisons of clinical features and outcomes between Elizabethkingia meningoseptica and other glucose non-fermenting Gram-negative bacilli bacteremia in adult ICU patients.
Chen WC; Chen YW; Ko HK; Yu WK; Yang KY
J Microbiol Immunol Infect; 2020 Apr; 53(2):344-350. PubMed ID: 30274894
[TBL] [Abstract][Full Text] [Related]
4. Risk factors and outcome of levofloxacin-resistant Elizabethkingia meningoseptica bacteraemia in adult patients in Taiwan.
Huang YC; Huang YW; Lin YT; Wang FD; Chan YJ; Yang TC
Eur J Clin Microbiol Infect Dis; 2017 Aug; 36(8):1373-1380. PubMed ID: 28265817
[TBL] [Abstract][Full Text] [Related]
5. Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems.
Lee CH; Su TY; Ye JJ; Hsu PC; Kuo AJ; Chia JH; Lee MH
J Microbiol Immunol Infect; 2017 Oct; 50(5):677-683. PubMed ID: 26188977
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the therapeutic efficacy of fluoroquinolone and non-fluoroquinolone treatment in patients with Elizabethkingia meningoseptica bacteraemia.
Huang YC; Lin YT; Wang FD
Int J Antimicrob Agents; 2018 Jan; 51(1):47-51. PubMed ID: 28668676
[TBL] [Abstract][Full Text] [Related]
7. Molecular epidemiology of carbapenem resistant gram-negative bacilli from infected pediatric population in tertiary - care hospitals in Medellín, Colombia: an increasing problem.
Vanegas JM; Parra OL; Jiménez JN
BMC Infect Dis; 2016 Sep; 16(1):463. PubMed ID: 27585707
[TBL] [Abstract][Full Text] [Related]
8. Clinical and microbiological analysis of Elizabethkingia meningoseptica bacteremia in adult patients in Taiwan.
Lin YT; Chiu CH; Chan YJ; Lin ML; Yu KW; Wang FD; Liu CY
Scand J Infect Dis; 2009; 41(9):628-34. PubMed ID: 19579148
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and outcomes for the acquisition of carbapenem-resistant Gram-negative bacillus bacteremia: A retrospective propensity-matched case control study.
Ting SW; Lee CH; Liu JW
J Microbiol Immunol Infect; 2018 Oct; 51(5):621-628. PubMed ID: 28732563
[TBL] [Abstract][Full Text] [Related]
10. Clinical Features and Risk Factors for Development of Breakthrough Gram-Negative Bacteremia during Carbapenem Therapy.
Lee JY; Kang CI; Ko JH; Lee WJ; Seok HR; Park GE; Cho SY; Ha YE; Chung DR; Lee NY; Peck KR; Song JH
Antimicrob Agents Chemother; 2016 Nov; 60(11):6673-6678. PubMed ID: 27572416
[TBL] [Abstract][Full Text] [Related]
11. Treatment and Outcome of Carbapenem-Resistant Gram-Negative Bacilli Blood-Stream Infections in a Tertiary Care Hospital.
Shah PG; Shah SR
J Assoc Physicians India; 2015 Jul; 63(7):14-8. PubMed ID: 26731822
[TBL] [Abstract][Full Text] [Related]
12. Clinical features, antimicrobial susceptibilities, and outcomes of Elizabethkingia meningoseptica (Chryseobacterium meningosepticum) bacteremia at a medical center in Taiwan, 1999-2006.
Hsu MS; Liao CH; Huang YT; Liu CY; Yang CJ; Kao KL; Hsueh PR
Eur J Clin Microbiol Infect Dis; 2011 Oct; 30(10):1271-8. PubMed ID: 21461847
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia and clinical impact of quinolone-resistant strains.
Kim EJ; Kim YC; Ahn JY; Jeong SJ; Ku NS; Choi JY; Yeom JS; Song YG
BMC Infect Dis; 2019 Aug; 19(1):754. PubMed ID: 31462215
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of aminoglycosides against clinical isolates of Acinetobacter baumannii complex and other nonfermentative Gram-negative bacilli causing healthcare-associated bloodstream infections in Taiwan.
Liu JY; Wang FD; Ho MW; Lee CH; Liu JW; Wang JT; Sheng WH; Hseuh PR; Chang SC
J Microbiol Immunol Infect; 2016 Dec; 49(6):918-923. PubMed ID: 26364729
[TBL] [Abstract][Full Text] [Related]
15. Non-susceptibility trends among Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria from bacteraemias in the UK and Ireland, 2001-06.
Livermore DM; Hope R; Brick G; Lillie M; Reynolds R;
J Antimicrob Chemother; 2008 Nov; 62 Suppl 2():ii55-63. PubMed ID: 18819980
[TBL] [Abstract][Full Text] [Related]
16. Gram-negative bacilli bacteremia: a 7 year retrospective study in a referral Brazilian tertiary-care teaching hospital.
Quillici MCB; Resende DS; Gonçalves IR; Royer S; Sabino SS; Almeida VF; Ribas RM; Gontijo Filho PP
J Med Microbiol; 2021 Jan; 70(1):. PubMed ID: 33258755
[No Abstract] [Full Text] [Related]
17. Association between antibiotic consumption and the rate of carbapenem-resistant Gram-negative bacteria from China based on 153 tertiary hospitals data in 2014.
Yang P; Chen Y; Jiang S; Shen P; Lu X; Xiao Y
Antimicrob Resist Infect Control; 2018; 7():137. PubMed ID: 30479750
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic susceptibility profiles of non-fermenting gram-negative Bacilli at a Tertiary Care Hospital in Patiala, India.
Grewal US; Bakshi R; Walia G; Shah PR
Niger Postgrad Med J; 2017; 24(2):121-125. PubMed ID: 28762368
[TBL] [Abstract][Full Text] [Related]
19. The impact of carbapenem resistance on clinical deterioration and mortality in patients with liver disease.
Ferstl PG; Filmann N; Brandt C; Zeuzem S; Hogardt M; Kempf VAJ; Müller M; Waidmann O; Reinheimer C
Liver Int; 2017 Oct; 37(10):1488-1496. PubMed ID: 28374901
[TBL] [Abstract][Full Text] [Related]
20. Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis.
Righi E; Peri AM; Harris PN; Wailan AM; Liborio M; Lane SW; Paterson DL
J Antimicrob Chemother; 2017 Mar; 72(3):668-677. PubMed ID: 27999023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
